Literature DB >> 15463414

Chronotherapy of malaria: an approach to malaria chemotherapy.

I Landau1, A Chabaud, G Cambie, H Ginsburg.   

Abstract

Chronotherapy is the science of the timing of drug application so as to achieve optimal therapeutic success for the treatment of disease. Here, Irene Landau, Alain Chabaud, Gilles Cambie and Hagai Ginsburg show how a suitable animal model can be chosen, how the stage of parasite development most susceptible to the drug can be identified, and how this can eventually be used for the improvement of drug treatment.

Entities:  

Year:  1991        PMID: 15463414     DOI: 10.1016/0169-4758(91)90218-d

Source DB:  PubMed          Journal:  Parasitol Today        ISSN: 0169-4758


  6 in total

1.  Synergistic in vitro antimalarial activity of omeprazole and quinine.

Authors:  T Skinner-Adams; T M Davis
Journal:  Antimicrob Agents Chemother       Date:  1999-05       Impact factor: 5.191

Review 2.  Assessment of the pharmacodynamic properties of antimalarial drugs in vivo.

Authors:  N J White
Journal:  Antimicrob Agents Chemother       Date:  1997-07       Impact factor: 5.191

3.  Synchrony in malaria infections: how intensifying within-host competition can be adaptive.

Authors:  Megan A Greischar; Andrew F Read; Ottar N Bjørnstad
Journal:  Am Nat       Date:  2013-12-16       Impact factor: 3.926

4.  Synchronization of Plasmodium yoelii nigeriensis and P. y. killicki infection in the mouse by means of Percoll-glucose gradient stage fractionation: determination of the duration of the schizogonic cycle.

Authors:  E Deharo; P Gautret; H Ginsburg; A G Chabaud; I Landau
Journal:  Parasitol Res       Date:  1994       Impact factor: 2.289

5.  Incorporating Stage-Specific Drug Action into Pharmacological Modeling of Antimalarial Drug Treatment.

Authors:  Eva Maria Hodel; Katherine Kay; Ian M Hastings
Journal:  Antimicrob Agents Chemother       Date:  2016-04-22       Impact factor: 5.191

6.  Daily rhythms of both host and parasite affect antimalarial drug efficacy.

Authors:  Alíz T Y Owolabi; Sarah E Reece; Petra Schneider
Journal:  Evol Med Public Health       Date:  2021-04-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.